Melanoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Melanoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Oct 25, 2018

---

• Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases.  
  Leichsenring Jonas et al. Pathology 2018 Oct
• Circulating cell-free DNA- diagnostic and prognostic applications in personalized cancer therapy.  
  Oellerich M et al. Therapeutic drug monitoring 2018 Oct
• Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.  
  Frieser Maia J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2018 Oct
• A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.  
  van Laar Ryan K et al. Melanoma research 2018 Oct
• Fast and Easy-to-Perform BRAF Testing in Melanoma Samples: An Accessible Tool for Pathologists With no Experience in Molecular Analyses.  
  Barel Fanny et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 Oct
• Cancer immunotherapy sweeps Nobel for medicine  
  J Kaiser et al, Science, October 4, 2018
• Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.  
  Helgadottir Hildur et al. Journal of medical genetics 2018 Oct
• CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.  
  Dalmasso Bruna et al. Journal of the American Academy of Dermatology 2018 Sep
• Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.  
  Sabarimurugan Shanthi et al. Molecular diagnosis & therapy 2018 Sep
• Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices.  
  Whitman Eric D et al. Future oncology (London, England) 2018 Sep